A detailed history of Vanguard Group Inc transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,836,560 shares of SRRK stock, worth $32.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,836,560
Previous 2,969,534 29.2%
Holding current value
$32.9 Million
Previous $52.7 Million 39.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.84 - $16.79 $6.8 Million - $14.6 Million
867,026 Added 29.2%
3,836,560 $32 Million
Q1 2024

May 10, 2024

BUY
$13.2 - $17.76 $1.51 Million - $2.03 Million
114,550 Added 4.01%
2,969,534 $52.7 Million
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $5.23 Million - $16.3 Million
802,266 Added 39.08%
2,854,984 $53.7 Million
Q3 2023

Nov 14, 2023

BUY
$6.02 - $7.76 $409,113 - $527,361
67,959 Added 3.42%
2,052,718 $14.6 Million
Q2 2023

Aug 14, 2023

BUY
$5.79 - $9.11 $638,995 - $1.01 Million
110,362 Added 5.89%
1,984,759 $15 Million
Q1 2023

May 15, 2023

SELL
$7.36 - $12.72 $76,176 - $131,652
-10,350 Reduced 0.55%
1,874,397 $15 Million
Q4 2022

Feb 10, 2023

BUY
$7.02 - $9.76 $3,692 - $5,133
526 Added 0.03%
1,884,747 $17.1 Million
Q3 2022

Nov 14, 2022

BUY
$5.33 - $11.3 $3.26 Million - $6.91 Million
611,159 Added 48.01%
1,884,221 $13.1 Million
Q2 2022

Aug 12, 2022

SELL
$4.66 - $13.96 $1.01 Million - $3.04 Million
-217,733 Reduced 14.61%
1,273,062 $6.99 Million
Q1 2022

May 13, 2022

BUY
$11.89 - $24.68 $462,723 - $960,471
38,917 Added 2.68%
1,490,795 $19.2 Million
Q4 2021

Feb 14, 2022

BUY
$24.14 - $35.18 $957,899 - $1.4 Million
39,681 Added 2.81%
1,451,878 $36.1 Million
Q3 2021

Nov 12, 2021

BUY
$27.38 - $42.21 $1.41 Million - $2.17 Million
51,473 Added 3.78%
1,412,197 $46.6 Million
Q2 2021

Aug 13, 2021

BUY
$26.34 - $46.62 $35.8 Million - $63.4 Million
1,360,724 New
1,360,724 $39.3 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $443M
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.